Studies on the control of hypertension. 8. Mortality, morbidity, and remissions during twelve years of intensive therapy.
D002714:Chlorisondamine / Q000627:therapeutic use*; D006145:Guanethidine / Q000627:therapeutic use*; D006584:Hexamethonium Compounds / Q000627:therapeutic use*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D008464:Mecamylamine / Q000627:therapeutic use*; D009026:Mortality; D010425:Pentolinium Tartrate / Q000627:therapeutic use*; D011379:Prognosis
D006584:Hexamethonium Compounds; D006830:Hydralazine; D008464:Mecamylamine; D010425:Pentolinium Tartrate; D002714:Chlorisondamine; D006145:Guanethidine